Concepedia

Jolana Marková

JM

Statistics

Publications

4

Citations

185

H-Index

4

Active since

1988

Affiliations

Charles University(Current)

Jolana Marková is an author at Charles University specializing in medicine, clinical trials, and pharmacotherapy.

Top concepts

Publications per year

1988–2018

4

Publications

4

Sativex <sup>®</sup> as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial

Jolana Marková, Ute Essner, Bülent Akmaz et al. · International Journal of Neuroscience · 2018 · 135 citations

Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.

G Waberzinek, Jolana Marková, Jiří Mastík · PubMed · 2007 · 19 citations

, , +8

Terguride in Parkinsonism a multicenter trial

M Filipová, Václav Filip, Z Macek et al. · European Archives of Psychiatry and Clinical Neuroscience · 1988 · 17 citations

, , +7

Eight cycles of BEACOPP escalated compared with 4 cycles of BEACOPP escalated followed by 4 cycles of BEACOPP baseline with or without radiotherapy in patients in advanced stage Hodgkin lymphoma (HL): Final analysis of the HD12 trial of the German Hodgkin Study Group (GHSG)

V. Diehl, Heinz Haverkamp, R.P. Mueller et al. · Journal of Clinical Oncology · 2009 · 14 citations

, , +23

1–4 of 4